Advisor Group Holdings, Inc. Biocryst Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 44,145 shares of BCRX stock, worth $473,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,145
Previous 13,383 229.86%
Holding current value
$473,675
Previous $100,000 231.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$7.06 - $9.39 $217,179 - $288,855
30,762 Added 229.86%
44,145 $331,000
Q4 2024

Feb 07, 2025
BUY
$7.03 - $8.43 $1,174 - $1,407
167 Added 1.26%
13,383 $100,000
Q3 2024

Nov 13, 2024
BUY
$6.41 - $8.69 $49,350 - $66,904
7,699 Added 139.55%
13,216 $100,000
Q2 2024

Aug 13, 2024
SELL
$4.13 - $6.79 $3.08 Million - $5.06 Million
-745,177 Reduced 99.27%
5,517 $34,000
Q1 2024

May 10, 2024
BUY
$4.89 - $7.65 $281,981 - $441,137
57,665 Added 8.32%
750,694 $3.81 Million
Q4 2023

Feb 12, 2024
BUY
$4.98 - $6.77 $217,680 - $295,923
43,711 Added 6.73%
693,029 $4.15 Million
Q3 2023

Nov 13, 2023
BUY
$6.71 - $7.92 $310,196 - $366,133
46,229 Added 7.67%
649,318 $4.6 Million
Q2 2023

Aug 10, 2023
BUY
$6.96 - $8.81 $285,554 - $361,456
41,028 Added 7.3%
603,089 $4.25 Million
Q1 2023

May 12, 2023
SELL
$7.94 - $11.84 $46,504 - $69,346
-5,857 Reduced 1.03%
562,061 $4.69 Million
Q4 2022

Feb 10, 2023
SELL
$10.5 - $14.2 $59,419 - $80,357
-5,659 Reduced 0.99%
567,918 $6.52 Million
Q3 2022

Nov 14, 2022
SELL
$10.79 - $14.81 $142,751 - $195,936
-13,230 Reduced 2.25%
573,577 $7.23 Million
Q2 2022

Aug 10, 2022
BUY
$7.89 - $17.88 $99,082 - $224,537
12,558 Added 2.19%
586,807 $6.21 Million
Q1 2022

May 04, 2022
BUY
$11.56 - $19.76 $748,856 - $1.28 Million
64,780 Added 12.72%
574,249 $9.34 Million
Q3 2021

Nov 05, 2021
BUY
$14.21 - $17.65 $1.33 Million - $1.65 Million
93,624 Added 22.51%
509,469 $7.32 Million
Q2 2021

Aug 02, 2021
BUY
$9.5 - $17.24 $257,906 - $468,031
27,148 Added 6.98%
415,845 $6.58 Million
Q1 2021

May 13, 2021
BUY
$7.37 - $13.61 $544,370 - $1.01 Million
73,863 Added 23.46%
388,697 $3.95 Million
Q4 2020

Feb 10, 2021
BUY
$3.37 - $8.61 $506,312 - $1.29 Million
150,241 Added 91.28%
314,834 $2.35 Million
Q3 2020

Nov 12, 2020
BUY
$3.43 - $5.53 $225,508 - $363,575
65,746 Added 66.51%
164,593 $565,000
Q2 2020

Aug 14, 2020
BUY
$1.9 - $5.61 $138,935 - $410,225
73,124 Added 284.27%
98,847 $471,000
Q1 2020

May 18, 2020
BUY
$1.6 - $4.11 $41,156 - $105,721
25,723 New
25,723 $51,000

Others Institutions Holding BCRX

# of Institutions
293
Shares Held
177M
Call Options Held
721K
Put Options Held
489K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $2B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email